GSK2190915 sodium |CAS:1196070-26-4 Probechem Biochemicals

Chemical Structure : GSK2190915 sodium

CAS No.: 1196070-26-4

加入收藏

货号: PC-44769Not For Human Use, Lab Use Only.

Fiboflapon (AM-803, GSK 2190915) sodium is a potent, selective 5-lipoxygenase-activating protein (FLAP) inhibitor with binding IC50 of 2.6 nM.

获取报价单

or Bulk Inquiry

大包装，大折扣！

E-mail: sales@probechem.com

Tech Support: tech@probechem.com

生物&药学活性

Fiboflapon (AM-803, GSK 2190915) sodium is a potent, selective 5-lipoxygenase-activating protein (FLAP) inhibitor with binding IC50 of 2.6 nM.

Fiboflapon (AM-803, GSK 2190915) inhibits LTB4 synthesis following ionophore challenge in human whole blood with IC50 of 76 nM (5 h incubation).

Fiboflapon (AM-803, GSK 2190915) shows good selectivity over CYP3A4, 2C9, and 2D6.

Fiboflapon (AM-803, GSK 2190915) exhibits excellent preclinical toxicology, pharmacokinetics and oral bioactivity.

分子量	659.8126
分子式	C38H42N3NaO4S
外观性状	Solid
CAS No.
储存条件	固体粉末 -20 °C 12 个月; 4°C 6 个月	配置液 -80 °C 6 个月; -20°C 6 个月
Shipping
Solubility	DMSO: ≥ 32 mg/mL
Chemical Name/SMILES	1H-Indole-2-propanoic acid, 3-[(1,1-dimethylethyl)thio]-1-[[4-(6-ethoxy-3-pyridinyl)phenyl]methyl]-α,α-dimethyl-5-[(5-methyl-2-pyridinyl)methoxy]-, sodium salt (1:1)

1. Stock NS, et al. J Med Chem. 2011 Dec 8;54(23):8013-29.

2. Lorrain DS, et al. Eur J Pharmacol. 2010 Aug 25;640(1-3):211-8.

3. Kent SE, et al. Clin Exp Allergy. 2013 Feb;43(2):177-86.